Emilio Paredes-Galan
Overview
Explore the profile of Emilio Paredes-Galan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez-Lopez A, Regueiro-Abel M, Paredes-Galan E, Johk-Casas C, Vieitez-Florez J, Elices-Teja J, et al.
J Clin Med
. 2025 Jan;
14(1.
PMID: 39797142
: Hyperkalemia is a common electrolyte disorder in patients with heart failure and reduced ejection fraction (HFrEF). Renin-angiotensin-aldosterone system inhibitors (RAASi) have been shown to improve survival and decrease hospitalization...
2.
Ortiz Cortes C, Rey-Sanchez P, Gomez Barrado J, Bover Freire R, Paredes-Galan E, Calderon-Garcia J, et al.
Med Clin (Barc)
. 2024 Sep;
163(11):549-556.
PMID: 39256078
Background And Objectives: Malnutrition is common in patients with heart failure (HF) and is associated with poor prognosis. We evaluated the prognostic and clinical impact of a nutritional intervention in...
3.
de Juan Baguda J, de Frutos F, Lopez-Vilella R, Couto Mallon D, Guzman-Bofarull J, Blazquez-Bermejo Z, et al.
Rev Esp Cardiol (Engl Ed)
. 2023 Jul;
77(4):290-301.
PMID: 37516313
Introduction And Objectives: Repetitive ambulatory doses of levosimendan are an option as a bridge to heart transplantation (HT), but evidence regarding the safety and efficacy of this treatment is scarce....
4.
Pazos-Lopez P, Paredes-Galan E, Peteiro-Vazquez J, Lopez-Rodriguez E, Garcia-Rodriguez C, Bilbao-Quesada R, et al.
Scand Cardiovasc J
. 2021 Jul;
55(5):279-286.
PMID: 34328392
. Echocardiography assessment from apical five-chamber view (A5CV) is the standard technique for aortic stenosis (AS) grading. Data on non-apical views, such as right parasternal (RPV), subcostal (SCV) and suprasternal...
5.
Trejo-Velasco B, Tello-Montoliu A, Cruz-Gonzalez I, Moreno R, Baz-Alonso J, Salvadores P, et al.
J Cardiovasc Pharmacol
. 2021 Jun;
78(3):463-473.
PMID: 34117181
The aim of our study is to assess the impact of anemia, chronic kidney disease, and diabetes mellitus on platelet reactivity (PR) in patients with severe aortic stenosis, both at...
6.
Trejo-Velasco B, Cruz-Gonzalez I, Tello-Montoliu A, Antonio Baz-Alonso J, Salvadores P, Moreno R, et al.
J Invasive Cardiol
. 2020 Aug;
32(12):446-452.
PMID: 32771996
Objectives: Ticagrelor has proven more effective than clopidogrel at attaining a maintained suppression of high platelet reactivity (HPR) in aortic stenosis patients undergoing transcatheter aortic valve implantation (TAVI). This study...
7.
Gonzalez-Guerrero J, Paredes-Galan E, Ferrero-Martinez A, Galan M, Hornillos-Calvo M, Menendez-Colino R, et al.
Rev Esp Geriatr Gerontol
. 2020 Feb;
55(4):195-200.
PMID: 32081386
Introduction: The latest European Society of Cardiology Heart Failure (HF) guidelines define three types of HF according to the ejection fraction (EF): HF with reduced EF (HFrEF) when EF<40%, HF...
8.
Solla-Ruiz I, Villanueva-Benito I, Paredes-Galan E, Salterain-Gonzalez N, Oria-Gonzalez G, De La Cuesta-Arzamendi F, et al.
Thromb Res
. 2019 May;
179:20-27.
PMID: 31075697
Introduction: Lack of INR controls might affect the adherence to direct oral anticoagulants (DOAC). The vast majority of studies that addresses adherence to anticoagulants are retrospective and based on pharmacy...
9.
Rodriguez-Pascual C, Torres-Torres I, Gomez-Quintanilla A, Ferrero-Martinez A, Sharma J, Guitian A, et al.
J Am Med Dir Assoc
. 2018 Jun;
19(11):936-941.
PMID: 29891182
Objective: The safety of direct oral anticoagulants (DOACs) in oldest old patients with nonvalvular atrial fibrillation (NVAF) in daily clinical practice has not been systematically assessed. This study examined the...
10.
Raposeiras-Roubin S, Abu-Assi E, Caneiro-Queija B, Cobas-Paz R, Rioboo-Leston L, Garcia Rodriguez C, et al.
Rev Port Cardiol (Engl Ed)
. 2018 Apr;
37(3):239-245.
PMID: 29606298
Introduction: Beta-blocker doses that have been shown to be effective in randomized clinical trials are not commonly used in daily clinical practice. The aim of this study was to analyze...